4.4 Article

Investigation of buprenorphine-related deaths using urinary metabolite concentrations

Related references

Note: Only part of the references are listed.
Editorial Material Anesthesiology

Buprenorphine: a treatment and cause of opioid-induced respiratory depression

Albert Dahan et al.

Summary: Buprenorphine, a partial agonist at the mu opioid receptor, is considered relatively safe due to its low maximum effect on respiratory depression. However, when combined with sedatives like benzodiazepines, it can cause serious respiratory depression.

BRITISH JOURNAL OF ANAESTHESIA (2022)

Article Substance Abuse

Concomitant drugs with buprenorphine user deaths

Claudia Mariottini et al.

Summary: This study investigated the role of emerging concomitant drugs in buprenorphine user deaths, finding a high prevalence of benzodiazepines, illicit drugs, and other substances in cases of buprenorphine poisoning. The study also highlighted the particularly unsafe drug use patterns in the younger age group, suggesting the need for targeted prevention strategies.

DRUG AND ALCOHOL DEPENDENCE (2021)

Article Psychology, Clinical

Use of non-prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration

Jan Gryczynski et al.

Summary: The study examined the use of non-prescribed buprenorphine in correctional and community contexts, finding higher use during incarceration and therapeutic motives for use in the community. Different characteristics were associated with non-prescribed buprenorphine use in different settings.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)

Article Biochemical Research Methods

Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography-tandem mass spectrometry

Claudia Mariottini et al.

Summary: A method using liquid chromatography-tandem mass spectrometry was developed for simultaneous quantification of buprenorphine and its metabolites in urine samples, without the need for a hydrolysis step. The method was able to cover the concentration ranges encountered in a clinical setting.

DRUG TESTING AND ANALYSIS (2021)

Article Chemistry, Analytical

Buprenorphine-Related Deaths in North Carolina from 2010 to 2018

Sandra C. Bishop-Freeman et al.

Summary: Buprenorphine is commonly prescribed for opioid use disorder, with cases of deaths involving BUP often complicated by the presence of other central nervous system depressants. Postmortem interpretation of BUP-related deaths is complex due to overlapping blood concentrations and the lack of a defined lethal range. Greater awareness of postmortem challenges is needed as access to OUD treatment expands and the use of BUP increases.

JOURNAL OF ANALYTICAL TOXICOLOGY (2021)

Review Psychiatry

Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence A Systematic Review and Meta-analysis

Thomas Santo Jr et al.

Summary: This systematic review and meta-analysis found that OAT was associated with lower rates of mortality. However, access to OAT remains limited, and insurance coverage remains low. Work to improve access globally may have important population-level benefits.

JAMA PSYCHIATRY (2021)

Review Substance Abuse

Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations

Marion A. Coe et al.

JOURNAL OF ADDICTION MEDICINE (2019)

Article Medicine, Legal

High buprenorphine-related mortality is persistent in Finland

Pirkko Kriikku et al.

FORENSIC SCIENCE INTERNATIONAL (2018)

Article Substance Abuse

Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice

Joseph H. Donroe et al.

DRUG AND ALCOHOL DEPENDENCE (2017)

Article Biochemical Research Methods

Urine naloxone concentration at different phases of buprenorphine maintenance treatment

Pertti Heikman et al.

DRUG TESTING AND ANALYSIS (2014)

Article Substance Abuse

Twelve-year trend in treatment seeking for buprenorphine abuse in Finland

Hanna Uosukainen et al.

DRUG AND ALCOHOL DEPENDENCE (2013)

Article Medicine, Legal

Parenteral buprenorphine-naloxone abuse is a major cause of fatal buprenorphine-related poisoning

Margareeta Hakkinen et al.

FORENSIC SCIENCE INTERNATIONAL (2013)

Article Substance Abuse

Gender differences in pharmacokinetics of maintenance dosed buprenorphine

David E. Moody et al.

DRUG AND ALCOHOL DEPENDENCE (2011)

Article Chemistry, Analytical

Urinary Detection Times and Metabolite/Parent Compound Ratios After a Single Dose of Buprenorphine

Robert Kronstrand et al.

JOURNAL OF ANALYTICAL TOXICOLOGY (2008)

Review Substance Abuse

Buprenorphine: The basic pharmacology revisited

Alan Cowan

JOURNAL OF ADDICTION MEDICINE (2007)